![Christopher Richard Hibberd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Richard Hibberd
Vorstandsvorsitzender bei Nucleix Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Kfir Oved | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 15 Jahre |
Eran Eden | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 15 Jahre |
Danny Frumkin | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 16 Jahre |
Patrick F. Terry | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 12 Jahre |
Frédéric Sweeney | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 5 Jahre |
Erez Chimovits | M | 60 |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 5 Jahre |
Adam Wasserstrom | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 16 Jahre |
Fred Witjes | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Ellen Bamberger | F | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Maria Ribal | F | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Louis Bont | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Israel Potasman | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Paul Feigin | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Scott Garrett | M | 74 |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 1 Jahre |
Thomas Buchholz | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 4 Jahre |
Haorui Patrick Zhang | M | 38 |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 7 Jahre |
Hanina Brandes | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Heiner Dreismann | M | 69 |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 8 Jahre |
Peter Seth Neustadter | M | 75 |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | - |
Tanya Gottlieb | M | - |
MeMed Diagnostics Ltd.
![]() MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Memed Diagnostics Ltd. engages in the development and commercialization of diagnostic solutions for inflammatory and infectious diseases. Its products include MeMed BV and MeMed Key, devices for blood test and quantitative diagnostic immunoassays. The company was founded by Eran Eden and Kfir Oved in 2009 and is headquartered in Tirat Carmel, Israel. | 10 Jahre |
Ilan Lior | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | 4 Jahre |
Martin Tammemägi | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Opher Shapira | M | - |
Nucleix Ltd.
![]() Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Israel | 23 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Christopher Richard Hibberd
- Persönliches Netzwerk